DRIVER REHABILITATION

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Risk Stratification in Primary Care Combined With Stratified-specific Physical Therapy Care for Low Back Pain

Not Applicable

Terminated

Conditions: Low Back Pain

Interventions: Other: Matched Physical Therapy Intervention
Other: Current Care in Family Medicine

First Posted Date: 2017-02-28

Last Posted Date: 2018-09-07

Lead Sponsor: University of Vermont Medical Center

Target Recruit Count: 90

Registration Number: NCT03065894

Locations: 🇺🇸
University of Vermont Medical Center, Burlington, Vermont, United States

Milk Fat Intake and Metabolic Health Markers

Not Applicable

Conditions: Type 2 Diabetes
Insulin Sensitivity

Interventions: Dietary Supplement: Milk Fat
Dietary Supplement: Control Fat

First Posted Date: 2016-01-20

Last Posted Date: 2016-10-26

Lead Sponsor: University of Vermont Medical Center

Target Recruit Count: 21

Registration Number: NCT02659748

Locations: 🇺🇸
Clinical Research Center, University of Vermont Medical Center, Burlington, Vermont, United States

The Efficacy of MEDIHONEY® for Chronic Rhinosinusitis With Nasal Polyposis After Functional Endoscopic Sinus Surgery

Not Applicable

Completed

Conditions: Chronic Sinusitis
Nasal Polyposis

Interventions: Device: MEDIHONEY®
Drug: Budesonide
Drug: Normal saline sinus rinse
Drug: Prednisone
Procedure: Endoscopic sinus surgery
Drug: nasal saline spray

First Posted Date: 2015-09-29

Last Posted Date: 2019-10-16

Lead Sponsor: University of Vermont Medical Center

Target Recruit Count: 40

Registration Number: NCT02562924

Locations: 🇺🇸
University of Vermont Medical Center, Burlington, Vermont, United States

Comparison of Prevena Negative Pressure Incision Management System vs. Standard Dressing After Vascular Surgery

Not Applicable

Conditions: Claudication
Peripheral Artery Disease
Critical Limb Ischemia

Interventions: Other: standard gauze dressing
Other: Prevena Incision Management system

First Posted Date: 2015-03-17

Last Posted Date: 2018-12-12

Lead Sponsor: University of Vermont Medical Center

Target Recruit Count: 242

Registration Number: NCT02389023

Locations: 🇺🇸
Maine Medical Center, Portland, Maine, United States
🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
University of Vermont Medical Center, Burlington, Vermont, United States

and more 2 locations

Interim Buprenorphine: Leveraging Medication + Technology to Bridge Delays in Treatment Access

Phase 1

Completed

Conditions: Opioid-related Disorders

Interventions: Drug: Interim Buprenorphine Treatment (IBT)

First Posted Date: 2015-02-10

Last Posted Date: 2018-05-03

Lead Sponsor: University of Vermont Medical Center

Target Recruit Count: 70

Registration Number: NCT02360007

Locations: 🇺🇸
Substance Abuse Treatment Center, University of Vermont, Burlington, Vermont, United States

Evaluation Of Transperineal Ultrasound For Image Guidance In The Treatment Of Prostate Cancer in Men Following Prostatectomy

Completed

Conditions: Post-Prostatectomy
Prostate Cancer

Interventions: Device: Transperineal Ultrasound

First Posted Date: 2014-04-10

Last Posted Date: 2017-05-03

Lead Sponsor: University of Vermont Medical Center

Target Recruit Count: 15

Registration Number: NCT02110667

Locations: 🇺🇸
Radiation Oncology, Fletcher Allen Healthcare, Burlington, Vermont, United States

A Quality Initiative to Improve Glycemic Control in Diabetic and Non-Diabetic Insulin Study

Completed

Conditions: Glycemic Control
Surgical Site Infections
Length of Stay
Cardiac Complications
Cost

Interventions: Drug: standard insulin protocol post-op (continuous IV insulin)

First Posted Date: 2013-08-06

Last Posted Date: 2016-10-25

Lead Sponsor: University of Vermont Medical Center

Target Recruit Count: 89

Registration Number: NCT01916733

Locations: 🇺🇸
Fletcher Allen Health Care, Burlington, Vermont, United States

Effective Treatment for Prescription Opioid Abuse

Phase 2

Completed

Conditions: Prescription Opioid Dependence

Interventions: Drug: buprenorphine taper followed by naltrexone maintenance
Behavioral: Behavioral therapy

First Posted Date: 2008-07-21

Last Posted Date: 2013-04-15

Lead Sponsor: University of Vermont Medical Center

Target Recruit Count: 105

Registration Number: NCT00719095

Locations: 🇺🇸
Substance Abuse Treatment Center, University of Vermont, Burlington, Vermont, United States

Incentive-based Smoking Cessation for Methadone Patients

Phase 2

Completed

Conditions: Cigarette Smoking Among Patients Currently Receiving Methadone or Buprenorphine Treatment for Opioid Dependence

Interventions: Behavioral: incentive-based contingency management

First Posted Date: 2008-07-21

Last Posted Date: 2014-02-21

Lead Sponsor: University of Vermont Medical Center

Target Recruit Count: 170

Registration Number: NCT00718835

Locations: 🇺🇸
Substance Abuse Treatment Center, University of Vermont, Burlington, Vermont, United States

Efficacy of Varenicline in Ambivalent Smokers

Phase 2

Completed

Conditions: Tobacco Use Disorder
Tobacco Use Cessation
Nicotine Dependence

Interventions: Drug: Placebo
Drug: Varenicline

First Posted Date: 2008-01-16

Last Posted Date: 2011-12-02

Lead Sponsor: University of Vermont Medical Center

Target Recruit Count: 220

Registration Number: NCT00595868

Locations: 🇺🇸
University of Vermont, Burlington, Vermont, United States
🇺🇸
Nebraska Medical Center, Omaha, Nebraska, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy